|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
31,570,000 |
Market
Cap: |
15.79(M) |
Last
Volume: |
540,567 |
Avg
Vol: |
539,072 |
52
Week Range: |
$0.1483 - $3.06 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile BrainStorm Cell Therapeutics is a biotechnology company engaged in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases including: Amyotrophic Lateral Sclerosis; Progressive Multiple Sclerosis; Alzheimer's disease; and other neurodegenerative diseases. NurOwn®, Co.'s proprietary platform, utilizes cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival and improve neurological function.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
11,500 |
11,500 |
Total Buy Value |
$0 |
$0 |
$20,402 |
$20,402 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
1 |
1 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Accbt Corp. |
10% Owner |
|
2011-01-23 |
4 |
OE |
$0.12 |
$1,260,000 |
D/D |
10,499,999 |
29,006,924 |
|
- |
|
Shorr Robert G L |
Director |
|
2010-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
300,000 |
|
- |
|
Taub Malcolm S |
Director |
|
2010-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
|
- |
|
Stolick David |
Chief Financial Officer |
|
2010-02-22 |
4 |
AS |
$0.36 |
$36,000 |
D/D |
(100,000) |
150,000 |
|
- |
|
Stolick David |
Chief Financial Officer |
|
2010-02-17 |
4 |
S |
$0.36 |
$720 |
D/D |
(2,000) |
250,000 |
|
- |
|
Stolick David |
Chief Financial Officer |
|
2010-02-16 |
4 |
S |
$0.36 |
$51,480 |
D/D |
(143,000) |
252,000 |
|
- |
|
Stolick David |
Chief Financial Officer |
|
2010-02-12 |
4 |
S |
$0.36 |
$1,800 |
D/D |
(5,000) |
395,000 |
|
- |
|
Shorr Robert G L |
Director |
|
2009-10-26 |
4 |
S |
$0.31 |
$12,440 |
D/D |
(40,000) |
100,000 |
|
- |
|
Shorr Robert G L |
Director |
|
2009-10-22 |
4 |
S |
$0.30 |
$9,700 |
D/D |
(30,000) |
140,000 |
|
- |
|
Javitt Jonathan C |
Director |
|
2009-10-22 |
5 |
S |
$0.32 |
$10,115 |
D/D |
(31,610) |
460,000 |
|
- |
|
Shorr Robert G L |
Director |
|
2009-10-21 |
4 |
S |
$0.29 |
$7,250 |
D/D |
(25,000) |
170,000 |
|
- |
|
Shorr Robert G L |
Director |
|
2009-10-20 |
4 |
S |
$0.28 |
$14,000 |
D/D |
(50,000) |
195,000 |
|
- |
|
Shorr Robert G L |
Director |
|
2009-10-19 |
4 |
S |
$0.27 |
$13,500 |
D/D |
(50,000) |
245,000 |
|
- |
|
Shorr Robert G L |
Director |
|
2009-10-16 |
4 |
S |
$0.28 |
$1,400 |
D/D |
(5,000) |
295,000 |
|
- |
|
Javitt Jonathan C |
Director |
|
2009-10-14 |
5 |
S |
$0.32 |
$19,200 |
D/D |
(60,000) |
491,610 |
|
- |
|
Javitt Jonathan C |
Director |
|
2009-10-06 |
5 |
S |
$0.34 |
$16,371 |
D/D |
(48,869) |
551,610 |
|
- |
|
Javitt Jonathan C |
Director |
|
2009-10-05 |
5 |
S |
$0.34 |
$29,324 |
D/D |
(87,509) |
600,479 |
|
- |
|
Javitt Jonathan C |
Director |
|
2009-10-02 |
5 |
S |
$0.34 |
$1,750 |
D/D |
(5,224) |
687,988 |
|
- |
|
Javitt Jonathan C |
Director |
|
2009-10-01 |
5 |
S |
$0.34 |
$952 |
D/D |
(2,800) |
693,212 |
|
- |
|
Javitt Jonathan C |
Director |
|
2009-09-30 |
5 |
S |
$0.32 |
$15,760 |
D/D |
(50,000) |
696,012 |
|
- |
|
Javitt Jonathan C |
Director |
|
2009-09-29 |
5 |
S |
$0.34 |
$71,986 |
D/D |
(213,988) |
746,012 |
|
- |
|
Taub Malcolm S |
Director |
|
2009-09-15 |
4 |
S |
$0.26 |
$59,108 |
D/D |
(225,000) |
675,000 |
|
- |
|
Taub Malcolm S |
Director |
|
2009-09-14 |
4 |
S |
$0.25 |
$87,990 |
D/D |
(350,000) |
900,000 |
|
- |
|
Taub Malcolm S |
Director |
|
2009-03-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,250,000 |
|
- |
|
Accbt Corp. |
10% Owner |
|
2008-09-08 |
4 |
OE |
$0.18 |
$749,925 |
D/D |
4,125,000 |
18,506,925 |
|
- |
|
211 Records found
|
|
Page 7 of 9 |
|
|